Cited by 116Ginkgo biloba and Cashew ApplicationsImmune Response and InflammationFlavonoids in Medical Research

Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide

Wadsworth, Teri L, Koop, Dennis R·2001·Chemico-Biological Interactions

Abstract

Administration of bacterial lipopolysaccharide (LPS) to laboratory animals and cultured macrophages is known to induce the production of nitric oxide (NO) from inducible nitric oxide synthase (iNOS). Here we show that pre-treatment with Ginkgo biloba extract (EGb 761) suppresses the in vivo production of NO (measured by the Griess reaction) after challenge with LPS. In order to begin to understand the mechanism of this inhibition, we evaluated in vitro effects of EGb 761 and its flavonoid component, quercetin, on LPS-treated RAW 264.7 macrophages. Pre-treatment with EGb 761 or quercetin dose-dependently inhibited NO release. Both substances scavenged NO generated from the decomposition of sodium nitroprusside. Western analysis showed that EGb 761 and quercetin inhibited LPS-induced levels of iNOS protein. Northern blotting demonstrated that EGb 761 and quercetin decreased LPS-induced iNOS mRNA levels without altering the half-life. Activation of mitogen activated protein kinases (MAPKs) and the redox-sensitive transcription factors, nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) are key events in the signal transduction pathways mediating iNOS induction. In our studies, both EGb 761 and quercetin inhibited p38 MAPK activity, which is necessary for iNOS expression in LPS-stimulated RAW 264.7 macrophages. However, differences in the response of NF-kappaB, AP-1, and Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) and its downstream substrates to EGb 761 and quercetin suggest that quercetin is not the sole component responsible for the in vivo inhibition of LPS-induced iNOS activation by EGb 761.

Integrity signals

Registry

Crossref · 10.1016/s0009-2797(01)00208-3

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LPS activates three subclasses of MAPKs in macrophages and other cells: ERK, JNK, and p38; some compounds suppress proinflammatory cytokines and NF-κB and inhibit COX-2 and iNOS expression by inhibiting some of these MAPKs.

    “In macrophages and other types of cells, LPS activates three subclasses of MAPKs: extracellular signal-regulated kinase (ERK), c-Jun-terminal kinase (JNK) and p38. Studies have revealed that some compounds are able to suppress proinflammatory cytokines and NF-κB, to inhibit the COX-2 and iNOS expression inhibiting some of these MAPKS [129,130,131].”

Cites

Flagged first, then by citations

3 of the 62 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wadsworth, T. L., & Koop, D. R.
Affiliations
Oregon Health & Science University (US)
Corresponding author
Koop, Dennis R
Venue
Chemico-Biological Interactions
Publisher
Elsevier BV
Published
2001-07
Volume
137
Issue
1
Pages
43-58
ISSN
0009-2797 (ISSN-L)
OpenAlex
W2035027020
Cited by
116
References
62
Citations by year
2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 3 · 2013: 7 · 2012: 5
FWCI
19.61
Type
journal article
Language
en
Open access
closed
Locations
  • Chemico-Biological Interactions (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Alcohol Abuse and Alcoholism (AA 08608)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
Keywords
Ginkgo biloba extract EGb 761, quercetin, lipopolysaccharide, nitric oxide, inducible nitric oxide synthase, macrophages, RAW 264.7 macrophages, p38 MAPK, NF-κB, AP-1, SAPK/JNK, flavonoids, anti-inflammatory activity, signal transduction
MeSH terms
Ginkgo Extract, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Inhibitors, Imidazoles, Lipopolysaccharides, Macrophages, Male, Mice, Inbred C57BL, Nitric Oxide, Nitroprusside, Plant Extracts, Pyridines, Quercetin, Tumor Necrosis Factor-alpha, Free Radical Scavengers, Nitric Oxide Synthase, Nitric Oxide Donors, Ginkgo biloba, Mice, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review